Leiner Plans Suit Against Dr. Reddy’s, Expects Delay Restarting OTC Business

Leiner Health Products' restart of its U.S. OTC operations could be delayed due to the loss of an exclusive ingredient supply contract with Dr. Reddy's Laboratories, the Carson, Calif.-based firm says